A5030962499- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Prostate Cancer Diagnosis and Treatment
- Urological Disorders and Treatments
- Prostate Cancer Treatment and Research
- MRI in cancer diagnosis
- Urologic and reproductive health conditions
- Urinary Tract Infections Management
- Urinary Bladder and Prostate Research
- Esophageal Cancer Research and Treatment
- Epigenetics and DNA Methylation
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Screening and Detection
- Testicular diseases and treatments
- Radiomics and Machine Learning in Medical Imaging
- Cancer Research and Treatments
- Renal cell carcinoma treatment
- Infectious Disease Case Reports and Treatments
- Advanced Radiotherapy Techniques
- Multiple and Secondary Primary Cancers
- Cancer Diagnosis and Treatment
- Genetic factors in colorectal cancer
- Radiopharmaceutical Chemistry and Applications
- Ovarian cancer diagnosis and treatment
- Immunotherapy and Immune Responses
Radboud University Nijmegen
2016-2025
Radboud University Medical Center
2016-2025
University Medical Center
2004-2023
Charles University
2023
Radboud Institute for Molecular Life Sciences
2018-2021
The Netherlands Cancer Institute
2018
European Organisation for Research and Treatment of Cancer
2016
Puigvert Foundation
2016
Jeroen Bosch Ziekenhuis
2012
Canisius-Wilhelmina Ziekenhuis
2008-2012
The role of adjuvant treatment in high-risk muscle-invasive urothelial carcinoma after radical surgery is not clear.
To retrospectively determine the relationship between apparent diffusion coefficients (ADCs) obtained with 3.0-T diffusion-weighted (DW) magnetic resonance (MR) imaging and Gleason grades in peripheral zone prostate cancer.The requirement to obtain institutional review board approval was waived. Fifty-one patients cancer underwent MR before prostatectomy, including DW b values of 0, 50, 500, 800 sec/mm(2). In prostatectomy specimens, separate slice-by-slice determinations grade groups were...
Purpose: To prospectively determine the accuracies of T2-weighted magnetic resonance (MR) imaging, dynamic contrast material–enhanced MR and quantitative three-dimensional (3D) proton spectroscopic imaging entire prostate for cancer localization, with whole-mount histopathologic section findings as reference standard. Materials Methods: This study was approved by institutional review board, informed consent obtained from all patients. Thirty-four consecutive men a mean age 60 years...
Undetected cancer in repeat transrectal ultrasound guided prostate biopsies patients with increased specific antigen greater than 4 ng/ml is a considerable concern. We investigated the tumor detection rate of suspicious regions on multimodal 3 Tesla magnetic resonance imaging and subsequent biopsy 68 men negative biopsies. compared results to those matched population. Also, we determined clinical significance detected tumors.A total 71 consecutive 2 or sessions underwent imaging. In this was...
Abstract Purpose: Early detection of prostate cancer can increase the curative success rate for cancer. We studied diagnostic usefulness TMPRSS2-ERG fusion transcripts as well combination antigen 3 (PCA3) RNA and in urinary sediments after digital rectal examination (DRE). Experimental Design: A total 78 men with cancer–positive biopsies 30 cancer–negative were included this study. After DRE, first voided urine was collected, obtained. used semiquantitative reverse transcription-PCR (RT-PCR)...